AG
AMRX icon

Advisor Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Advisor Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
300
– – ﹤0.01% 5087
2019
Q3 		$1K Hold
300
– – ﹤0.01% 5073
2019
Q2 		$2K Sell
300
-3,063
-91% -$31.3K ﹤0.01% 4946
2019
Q1 		$48K Buy
3,363
+162
+5% +$2.14K ﹤0.01% 3408
2018
Q4 		$43K Buy
3,201
+132
+4% +$2.38K ﹤0.01% 3280
2018
Q3 		$68K Buy
3,069
+543
+21% +$11.4K ﹤0.01% 3053
2018
Q2 		$42K Buy
+2,526
New +$44.3K ﹤0.01% 3229

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Group's AMRX Position: Q4 2019 in Review

Advisor Group held its Amneal Pharmaceuticals (AMRX) position steady in Q4 2019 at 300 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5087.

Advisor Group first reported a position in AMRX in Q2 2018 and has held it in 7 quarters since. The position peaked at $68K in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q4 2019.

  • Advisor Group held 300 shares of Amneal Pharmaceuticals worth $1K as of Q4 2019.
  • Advisor Group left its Amneal Pharmaceuticals share count unchanged in Q4 2019.
  • Amneal Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5087 holding.
  • Advisor Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
  • Advisor Group's Amneal Pharmaceuticals position peaked at $68K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.